Bicycle Therapeutics PLC (BCYC)
22.06
+0.21
(+0.96%)
USD |
NASDAQ |
May 15, 14:23
Bicycle Therapeutics Cash from Operations (Quarterly): -70.87M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -70.87M |
| December 31, 2023 | -47.29M |
| September 30, 2023 | -1.025M |
| June 30, 2023 | 34.10M |
| March 31, 2023 | -46.41M |
| December 31, 2022 | -30.31M |
| September 30, 2022 | -5.871M |
| June 30, 2022 | -23.53M |
| March 31, 2022 | -26.40M |
| December 31, 2021 | -10.44M |
| September 30, 2021 | 21.72M |
| June 30, 2021 | -12.37M |
| March 31, 2021 | -13.71M |
| Date | Value |
|---|---|
| December 31, 2020 | -16.62M |
| September 30, 2020 | -9.985M |
| June 30, 2020 | -12.35M |
| March 31, 2020 | 21.16M |
| December 31, 2019 | -4.919M |
| September 30, 2019 | -10.88M |
| June 30, 2019 | -7.608M |
| March 31, 2019 | -5.201M |
| December 31, 2018 | -8.854M |
| September 30, 2018 | -4.658M |
| June 30, 2018 | -5.293M |
| March 31, 2018 | -7.273M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-70.87M
Minimum
Mar 2024
34.10M
Maximum
Jun 2023
-13.68M
Average
-11.62M
Median
Cash from Operations (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 0.4825M |
| TC BioPharm (Holdings) PLC | -- |
| Adaptimmune Therapeutics PLC | -14.68M |
| Verona Pharma PLC | -13.61M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.012M |
| Cash from Financing (Quarterly) | 1.871M |
| Free Cash Flow | -85.93M |
| Free Cash Flow Per Share (Quarterly) | -1.665 |
| Free Cash Flow to Equity (Quarterly) | -70.98M |
| Free Cash Flow to Firm (Quarterly) | -70.88M |
| Free Cash Flow Yield | -10.06% |